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Summary 
Aim. To evaluate the effect of an educational intervention among primary care physicians on several indicators of 
good clinical practice in diabetes care. 
Methods. Two groups of physicians were randomly assigned to the intervention or control group (IG and CG). Every 
physician randomly selected two samples of patients from all type 2 diabetic patients aged 40 years and above and 
diagnosed more than a year ago. Baseline and final information were collected cross-sectionally 12 months apart, in 
two independent samples of 30 patients per physician. The educational intervention comprised: distribution of 
educational materials and physicians' specific bench-marking information, an on-line course and three on-site 
educational workshops on diabetes. External observers collected information directly from the physicians and from 
the medical records of the patients on personal and family history of disease and on the evolution and treatment of 
their disease. Baseline information was collected retrospectively in the control group. 
Results. Intervention group comprised 53 physicians who included a total of 3018 patients in the baseline and final 
evaluations. CG comprised 50 physicians who included 2868 patients in the same evaluations. Measurement of 
micro-albuminuria in the last 12 months (OR = 1.6, 95% CI: 1.1–2.4) and foot examination in the last year (OR = 2.0, 
95% CI: 1.1–3.6) were the indicators for which greater improvement was found in the IG. No other indicator 
considered showed statistically significant improvement between groups. 
Conclusions. The identification of indicators with very low level of compliance and the implementation of a simple 
intervention in physicians to correct them is effective in improving the quality of care of diabetic patients. 
Introduction 
Diabetes is a common disease, with an estimated prevalence in Spain of 13.8% of the population aged 
18 years or more, showing higher percentages in the age groups above 60 years [1]. In Europe, prevalence 
ranges between 10% and 20%, with higher prevalences among the older age groups (60–79 years old) [2-
4]. 
Diabetes is a chronic disease associated with the development of macro- and microvascular 
complications. The incidence of these complications increases with the duration of the disease. Up to 20% 
of the population with diabetes will have a cardiovascular event 10 years after diagnosis [5], and more 
than 25% of this population will have some degree of retinopathy [6]. Worldwide as well as in Spain, 
with small local variations, diabetes is the first cause of terminal renal disease, as measured by the 
number of those admitted for dialysis programmes [7]. Health costs of diabetes are very high and directly 
related to the time since diagnosis and to the presence of complications and hospital admissions [8, 9]. 
The Statement of Saint Vincent [10] defined aims for the fight against diabetes complications to be 
used by governments and other organisations. Following these principles, different groups designed 
specific indicators to evaluate the process and the results of treatment of diabetic patients, the usefulness 
of which was proven by an improvement in quality [11-13]. 
Adequate metabolic control, as well as control of other cardiovascular risk factors, is essential to 
prevent complications of diabetes [5, 14-16]. Early detection and control of these complications also 
improves the medium- and long-term prognosis [17, 18]. That is why different societies and organisations 
have designed guidelines for the diagnosis and treatment of diabetic patients [19-22]. Nevertheless, there 
is a gap between the guidelines and their application in the clinical setting among type 2 diabetic patients 
[23-26]. This study evaluates an intervention among primary care physicians aimed at reducing the gap 
between guideline recommendations and clinical practice regarding diabetic patients. 
 
Methods 
Study design 
The study was conducted in Galicia (north-west Spain) and consisted of two independent cross-sectional 
evaluations performed 1 year apart (2008 and 2009). Between the evaluations, an intervention was 
implemented among the physicians of the intervention group (IG). In the control group (CG), baseline 
data collection was done retrospectively, coinciding with the final evaluation (Figure 1). 
 
 
 
Figure 1. Participation and study design flow-chart 
Participants 
Participating physicians were selected by stratified random sampling (by primary care area) from the list 
of physicians with a stable job, without any intention to change place of work in the immediate future and 
with an assigned population of at least 500 people aged 40 or over. The control group was recruited 
immediately before the second cut to avoid modifications in behaviour between the evaluations owing to 
participation in the study. 
Selection of diabetic patients 
Each participating physician provided information from 30 diabetic patients, randomly selected from the 
total list of diabetic patients aged 40 years and above and with more than 1 year of diagnosis of type 2 
diabetes. There were two independent sampling processes. Women with gestational diabetes were 
excluded from the study. 
Sampling considerations 
Sample size was calculated to detect an absolute difference of 5% between the two groups at the end of 
the intervention in accomplishment of the indicators analysed, assuming a proportion of 50% in the 
control group and with errors α = 0.05 and β = 0.2 (power = 0.8)  
Data collection 
Participating physicians answered a questionnaire with demographic characteristics and data from their 
workplace, whereas information on the patients was obtained from the patient medical records by a team 
of independent trained nurses. This included: social and demographic data, family and personal history of 
disease, characteristics of the patient's diabetes, anthropometry and analytical data. Body mass index 
(BMI) was computed (weight/height2) and classified as normal (18.5 ≤ BMI < 25), overweight (25 ≤ BMI 
< 30) and obesity (BMI ≥ 30). The criterion of Adult Treatment Panel- III (ATP-III) was used for central 
obesity (waist circumference ≥ 102 centimetres in men and ≥ 88 centimetres in women). Indicators used 
to assess quality of care, derived from the ‘Health Plan’ of Galicia [27], were previously defined in detail 
[26]. 
Educational intervention 
Baseline results [26] were used to identify needs and define the intervention to be implemented in the IG. 
It comprised the following activities through 6 months: 
Bench-marking (audit and feedback) 
Overall results were presented to the participating physicians in a group session. Every physician received 
the data from his/her own practice, which allowed him/her to compare every indicator with peers. 
Teaching activities 
(i) Delivery of printed material on DM-2: a Clinical Guide and materials to facilitate (developing 
automatisms) the management of the diabetic patient. (ii) A comprehensive on-line course that included 
reading and reference materials, learning tasks (problem-solving based on clinical scenarios) and other 
teaching resources (forum, tutorial and case-resolution). The course also included a final test to evaluate 
the students. Those who completed the course were given 12.5 h in CME credits. The on-line platform 
that remained open 1 month permitted adapting the completion of the course to the personal time 
availability of every participating physician thus facilitating completion of the course. (iii) Face-to-face 
training workshops on management of type 2 diabetes: in 1 day, there were three consecutive workshops 
of 90 min each on the following topics: (i) diagnosis, management and control objectives in DM-2; (ii) 
therapeutic update in type 2 diabetes; (iii) how to explore the diabetic foot. CME credits were given to the 
participating physicians in the workshops. 
Statistical analysis 
Mean and standard deviation (SD) or proportion were used to describe the characteristics of physicians 
and patients. In every evaluation (baseline and final), IG and CG were compared by means of Student t-
test, Mann–Whitney U-test or Chi-squared (adjusted by the cluster effect of the physician). 
Proportion (and 95% confidence interval) of compliance of every quality indicator was estimated in 
every group (IG and CG) and the hypothesis of equality pre- and post-intervention was tested by means of 
corrected Chi-square. 
In the final evaluation, a logistic regression model was developed to compare the fulfilment of criteria 
between the intervention and control groups. The dependent variable in each model was the 
corresponding indicator (1 = compliant, 0 = non-compliant) and the independent variable was the group 
(intervention-control); other variables included in the model for adjustment were characteristics of the 
patient and the proportion of compliance of each physician at baseline. Finally, the physician was 
considered as a clustering variable to adjust the variance. The adjustment variable was defined as follows: 
(i) the percentages of compliance of each doctor in the baseline were calculated, (ii) each patient's final 
cross-section was given the basal rate for their physician. CG was the reference group for calculating the 
adjusted OR: therefore, an OR > 1 indicated that belonging to the IG improved the performance of the 
indicator, and an OR < 1 indicated that it worsened the performance. Adjusted OR and 95% confidence 
intervals are presented.  
Ethical issues 
The study was approved by the Ethical and Clinical Research Committee of Galicia. All patients received 
information about the study and signed an informed consent form. Information from diabetic patients was 
collected anonymously and the individual evaluations of physicians were treated as confidential. 
Results 
Five of the 58 physicians of the IG did not complete the study for important reasons (death, illness and 
three changes of workplace), giving a completion rate of 91%. Data for the remaining 53 physicians who 
completed the study are presented in Figure 1. 
Regarding participation in the different components of the intervention: (i) Every physician (100%) in 
the IG received the feedback information in electronic support and the written materials in his workplace. 
(ii) 71% attended the presentation of baseline results and bench-marking. (iii) 82% followed the on-line 
course and 85% participated in the formative workshops on diabetes. Overall, 76% of the physicians 
participated in at least two of the three components of the intervention (42% participated in all three). 
There are no differences between the two groups in the characteristics of the physicians and their clinical 
practices (Table 1). 
Table 1. Characteristics of primary care physicians. Comparison of the groups 
 Intervention (n = 53)  Control (n = 50)  
 n  Value  n  Value p-value 
       
Gender (men) 53 52.8  50 46.0 0.488 
Age in years (mean) (SD) 52 50.6 (4.1)  37 49.0 (3.5) 0.057 
Professional activity in years (median) (IR) 48 25.5 (7.5)  37 22.0 (7) 0.346 
MIR training* 51 17.7  39 23.1 0.523 
Type of centre (urban) 52 51.9  40 35.0 0.162 
Integrated practice 28 96.4  17 94.1 0.715 
Nursing consultation 52 94.2  43 93.0 0.810 
MIR training performed in their health centre 53 37.7  41 26.8 0.265 
Tutor of FCM residents 52 13.5  40 17.5 0.593 
Diabetological education** 52 94.2  41 87.8 0.273 
Education done by physician and nurse 49 69.4  36 75.0 0.844 
       
 
Results in percentages (unless otherwise stated). IR, interquartile range. *MIR training: professionals who were trained in family 
and community medicine (FCM) for at least 3 years after graduating in Medicine. †Type of centre where they work (urban or rural). 
‡Integrated practice: Full time family physicians. §Nursing consultation: Nurse who has her own and independent consultation from 
the physician. ¶Tutor of FCM residents: the participating physician is tutor of FCM physicians in training. **Diabetological 
education: Diabetic patients are educated in diabetes. 
Table 2 compares the groups of patients. Differences between the intervention and control groups are 
slight and not statistically significant, except for some variables at baseline such as family history of 
ischaemic heart disease, personal history of prior coronary revascularisation, presence of neuropathy and 
insulin use. Some differences in the variables favour one group and others the other one. 
  
Table 2. Characteristics of patients included. Comparison between intervention and control groups at baseline and final exam 
 Baseline 
 
Final 
 
Intervention 
(n = 1501) 
Control 
(n = 1437) 
p-
value 
 
Intervention 
(n = 1517) 
Control 
(n = 1431) 
p-
value 
        
Gender    0.804    0.676 
Men 52.1 52.7   52.4 51.6  
Age    0.100    0.268 
< 60 20.1 17.5   19.1 18.1  
60–69 27.9 26.0   28.7 26.2  
≥ 70 52.0 56.6   52.3 55.7  
Employment status    0.550    0.223 
Paid work 21.3 20.1   21.9 18.4  
Unpaid work 5.6 4.2   5.3 3.9  
Retired 73.1 75.8   72.8 77.7  
HBP (yes)  71.1 73.6 0.307  76.3 75.2 0.627 
Diet 89.6 87.1 0.578  87.4 84.5 0.627 
Pharmacological treatment 93.1 90.8 0.212  90.8 94.1 0.099 
Hypercolesterolaemia (yes)  53.4 58.7 0.265  57.8 59.8 0.606 
Diet 90.3 85.5 0.318  85.2 82.2 0.671 
Pharmacological treatment 83.9 85.3 0.665  82.3 86.3 0.225 
Smoking habit    0.113    0.642 
Smoker 9.1 11.7   9.8 11.1  
Ex-smoker 16.8 18.2   18.2 17.5  
Never smoked 74.0 70.1   72.0 71.4  
Personal history        
Relatives with sudden death or 
IHD 
11.9 19.4 0.005 
 
17.3 19.3 0.460 
Myocardial infarction 5.3 6.0 0.454  6.4 5.7 0.415 
Angina pectoris 4.8 5.2 0.689  6.7 5.5 0.335 
Prior revascularization 3.7 11.8 0.000  12.5 13.4 0.836 
Heart failure 7.3  0.792    0.851 
Stroke 6.5 7.1 0.599  7.3 7.5 0.892 
Peripheral artery disease 
(PAD) 
5.2 4.9 0.790 
 
5.9 5.6 0.835 
Years since diagnosis of 
diabetes, mean (SD) 
8.7 (6.8) 8.9 (5.8) 0.072 
 
9.1 (6.7) 9.0 (6.0) 0.754 
Complications of diabetes        
Retinopathy 9.3 9.1 0.877  10.2 9.8 0.842 
Nephropathy 4.9 5.3 0.680  5.0 6.6 0.218 
Neuropathy 4.1 2.0 0.029  2.4 1.8 0.238 
Control of glycaemia 36.1 27.5 0.055  30.0 30.7 0.856 
Diabetes dietetic (yes)  90.6 85.7 0.187  86.6 82.6 0.476 
Quantitative 3.6 2.1   3.1 3.0  
Qualitative 78.0 95.4   92.5 94.1  
Both 18.4 2.5   4.4 3.0  
Calories, mean (SD) 1551.7 (176.1) 
1523.6 
(239.9) 
0.547 
 
1539.9 (224.4) 
1509.7 
(196.8) 
0.776 
Oral antidiabetic drugs 76.5 73.1 0.894  81.3 77.3 0.108 
Insulin 19.9 12.1 0.000  16.7 14.4 0.195 
BMI    0.729    0.581 
Non-obese 38.5 36.8   39.6 37.6  
Overweight 9.0 9.2   9.2 10.2  
Obesity 52.5 54.0   51.2 52.2  
Central obesity (ATP-III)        
Men 55.7 56.8 0.929  61.8 59.3 0.764 
Women 87.8 96.2 0.235  87.1 95.1 0.171 
BP > 130/80 mmHg 19.0 19.7 0.769  18.3 16.8 0.557 
ECG (last 2 years)    0.126    0.206 
Normal 66.4 62.2   64.4 58.3  
Pathological 33.6 37.8   37.6 41.7  
        
 
Results in percentages (unless otherwise stated). HBP, high blood pressure (if mean arterial pressure is above 130/80); IHD, 
ischaemic heart disease; BMI, body mass index; ATP-III, Central obesity according to the ‘Adult Treatment Panell III’; BP, blood 
pressure; ECG, electrocardiogram.  
The degree of accomplishment of the indicators in each group before and after the intervention and the 
comparison of the two groups in the final exam are presented in Table 3. All indicators related to the 
measurement of risk factors (blood pressure, LDL-cholesterol) have a compliance rate of more than 75% 
in both groups and at baseline and final exam. The IG had statistically significant improvement in both 
the micro-albuminuria and foot examination indicators. 
Table 3. Quality of care. Absolute degree of compliance of indicators in both groups before and after educational intervention and comparison between 
both groups at the final cross-section 
 Intervention group  Control group  
Final evaluation 
(adjusted) 
 
Baseline % 
(95% CI) 
Final % 
(95% CI) 
p-
value 
 
Baseline % 
(95% CI) 
Final % 
(95% CI) 
p-
value 
 
OR % (95% 
CI) 
p-
value 
           
Glycated haemoglobin measurement* 54.3 (49.1–
59.5) 
57.4 (52.8–
62.0) 
0.319  50.3 (44.2–
56.4) 
54.2 (49.0–
59.4) 
0.156  1.1 (0.8–1.4) 0.584 
BP measurement 85.9 (82.7–
89) 
87.7 (84.6–
90.7) 
0.355  83.4 (79.0–
87.9) 
83.5 (79.1–
87.9) 
0.961  1.2 (0.9–1.8) 0.234 
If mean average BP is above 130/80, 
is there a specific monitoring and/or 
treatment plan?* 
35.7 (27.1–
44.3) 
28.8 (20.6–
37.0) 
0.240  31.1 (20.0–
42.3) 
25.8 (16.2–
35.2) 
0.026  1.0 (0.5–1.8) 0.911 
LDL measurement 78.6 (74.8–
82.5) 
80.2 (77.1–
83.3) 
0.488  77.1 (72.4–
81.8) 
76.2 (72.4–
79.9) 
0.703  1.2 (0.9–1.6) 0.117 
If total cholesterol is > 200 mg/dl or 
LDL > 100 mg/dl, did this cause 
diagnosis and/or treatment to 
change?* 
27.3 (19.6–
35) 
20.7 (13.9–
27.5) 
0.191  26.1 (16.2–
36.1) 
21.212.5–
29.9) 
0.070  0.9 (0.5–1.8) 0.844 
Recommendation of physical exercise 63.8 (54.5–
73) 
77.0 (69.8–
84.2) 
0.036  74.9 (66.3–
83.6) 
75.4 (66.7–
84.1) 
0.860  1.4 (0.7–2.6) 0.373 
Eye examination 35.4 (29–
41.7) 
36.5 (30.1–
43.0) 
0.720  25.1 (19.9–
30.4) 
27.6 (23.0–
32.2) 
0.150  1.2 (0.9–1.6) 0.343 
Micro-albuminuria measurement 43.2 (34.9–
51.4) 
50.6 (44.2–
57.1) 
0.067  31.7 (25.0–
38.4) 
33.6 (26.6–
40.6) 
0.428  1.6 (1.1–2.4) 0.009 
Micro-albuminuria measurement, 
< 75 years old without nephropathy 
44.4 (36.2–
52.7) 
52.7 (46.1–
59.2) 
0.043  32.2 (25.6–
38.8) 
34.1 (27.1–
41.0) 
0.481  1.8 (1.2–2.6) 0.002 
Foot examination, measuring at least 
peripheral pulses 
19.5 (12.9–
26) 
30.1 (21.3–
38.9) 
0.015  9.8 (4.6–
15.0) 
14.0 (7.9–
20.2) 
0.011  2.0 (1.1–3.6) 0.023 
           
 
*Last 6 months; †Last 12 months; ‡Last 24 months; §The variance of the ORs was adjusted in every model by the cluster effect of 
several patients being treated by the same physician. The logistic regression model for every indicator also included as covariate the 
baseline situation for that particular indicator (see 'Methods'). LDL, low-density lipoprotein. 
Figure 2 shows an example of two indicators with different responses to the intervention. For the foot 
examination during the last year, there was improvement in the IG (from 19.5% to 30.1%) compared with 
the CG (from 9.8% to 14%) (p = 0.023). Measuring the glycated haemoglobin in the past 6 months 
improved similarly in both groups (p = 0.584). 
  
 
 
 
Figure 2. Foot examination and glycosylated haemoglobin measurement. Compliance and difference between intervention and 
control groups./LEGEND: The p-value shows the signification of the OR. The OR compares the compliance of the corresponding 
indicator in the IG vs. the CG in the final evaluation, adjusting for baseline situation 
Discussion 
This study shows that an intervention such as the one performed here, including an audit with 
personalised feedback and teaching activities (face-to-face and on-line), can achieve improvements of 
modest magnitude in selected quality of care indicators among diabetic patients, especially those who are 
far from optimal compliance at baseline. 
This finding largely corresponds with that presented in other studies [24, 28, 29], especially those 
where multifactorial interventions have been performed. In our case, the designed intervention aimed at 
primary care physicians in the public health system was based on the results of a baseline study [26] to be 
viable in our health system and repeatable in the future. 
Within a multifactorial intervention such as the one performed here (the type recognised as the most 
useful) [28-34], it is very difficult to assess the effectiveness of each of the procedures, but it would be of 
great help to be able to focus efforts on these activities. In our project, special relevance was given to the 
audit and feedback, as well as the activities of interactive format (face-to-face workshops, on-line 
courses). These, generally, have proved to be more useful than didactic materials [23, 28, 30, 31, 35-38]. 
This is particularly true when high participation is achieved, as in this case. 
As regards the materials used, we believe that some such as the ‘leaflet’ pocket or desk material may, 
by virtue of their ease of access and readability, be useful for the development of automatisms in clinical 
practice. 
It has been reported that concentrating on just a few specific issues with a low degree of compliance 
improves the outcome [23, 33, 36, 39]. Our intervention was not directed specifically at these issues, but 
the analysis at baseline allowed us to identify key points where the situation was worse and consider them 
in designing the intervention. This may partly explain the improvement in some indicators. For example, 
there was a workshop specifically dedicated to the examination of the foot, and in another, in which the 
follow-up plan was reviewed, we discussed the indicators with lowest compliance. In addition, bench-
marking and corresponding feedback allow every physician to make the necessary improvements. 
Special consideration needs to be given to the examination of the eye, in which, despite low baseline 
compliance, no significant improvement was observed. A possible explanation may be that this 
exploration in Spain is predominantly performed by an ophthalmologist, to whom the patient has to be 
referred. This process may complicate and slow down the accomplishment of this indicator, particularly 
considering the usual long delay between the time of the referral and the appointment with the 
ophthalmologist. This is one of those barriers attributable to the system, which in many cases are more 
difficult to address [25] and may explain part of the gap between knowledge and usual clinical practice 
[40], which cannot be modified by the intervention performed. 
One possible limitation is the ‘Hawthorne’ effect, i.e. improvement attributable to being observed. 
Although the health administration did not take part and all information was treated anonymously, the IG, 
but not the CG, was aware of being evaluated. Our interpretation is that knowing that one is being 
evaluated can be considered part of the intervention, something to be considered in future improvement 
programmes. 
Another potential limitation is the possibility of ‘contamination’ of the CG by the IG, as both worked 
in the same healthcare system. Although this cannot be entirely ruled out, we tried to limit the damage by 
the late inclusion of the CG in the study and the retrospective collection of basal data in this group. 
The low participation rate of physicians (32 and 33% in both IG and CG) may limit the 
generalisability of the results. Although it is difficult to verify, in favour of the study, we do know that the 
participating physicians do not differ in basic characteristics from the population from which they derive 
[26], suggesting non-selective participation. 
It should also be mentioned that the intervention, although multifactorial, is only aimed at the 
physician. Although it is known that effectiveness improves when all team members are involved and 
there is an opportunity to make structural changes [28, 41-44], this was considered unfeasible in our case. 
One of the strengths and a singularity of our study is the analysis by participating physicians. The fact 
that the information was collected by independent teams reduced the possibility of bias as well as the 
workload of the participating physicians, facilitating their participation. 
There is still room for improvement in type 2 diabetes care, particularly in some of these indicators. It 
is necessary to continue efforts to identify effective interventions that could improve them further, such as 
those that treat the entire organisational system and target all the team members capable of modifying 
complex problems. 
The main conclusion of this study is that the identification of variables with very poor compliance and 
the implementation of a simple intervention among physicians aimed to correct them are effective in the 
improvement of the quality of care of diabetic patients. 
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List of participating physicians [OBTEDIGA project]: 
Coordinating Group: Vidal Pardo, JI; López Álvarez, XL; García Soidán, FJ; López Vázquez, P; Mato 
Mato, JA; do Muíño Joga, M; Jorge Méndez, S; López Fernández, MD; Muñiz, J; 
Primary Care Medical Group: Gerencia de Atención Primaria (G.A.P.) A Coruña: de Alcalá Torreiro, 
EM; de Aspe de la Iglesia, EM; Eirís Pérez, R; Esmorís Méndez, M; Garea Cao, B; López Pan; MM; 
López Toledo, ML; Mesía Alonso, MJ; Pena Babío, MT; Rey López, A; Veras Castro, R; Vigo Arcas, A; 
Zapata Medín, ML; G.A.P. Ferrol: Alvarez Escudero, A; Cameo Chenlo, MP; Castro Blanco, A; García 
del Río, ME; Martínez González, A; G.A.P. Lugo: Álvarez Ferreiro, MI; Campo Dieguez, FJ; Castiñeira 
Pérez, MC; Cobo Domínguez, C; Cobo Rodríguez, B; Fontenla Villamarín, A; Fouz Ulloa, A; García 
Sierra, A; González-Anleo Rodríguez, MF (†); López Lens, M; López Martín, I; Martínez González, M; 
Mourín González, MF; Navaza Dafonte, AM; Palmeiro Díaz, M; Parada Mariñas, R; Pensado Barbeira, 
F; Porto Iglesias, JA; Rodríguez Suárez, F; Santos García, MC; Valledor Puente, JF; Vázquez Gómez, T; 
Vázquez Seijas, EJ; Vázquez Vázquez, MJ; G.A.P. Pontevedra: Carrera Ligero, JM; Cores Abalo, M; 
Fuente Martín, LM; Meijide Calvo, LM; Ogando Canabal, AM; Onega Díaz, C; Sánchez Castro, JJ; 
Segovia Castro, L; Yun Casalilla, MT; G.A.P. Vigo: Dapena Sánchez, R; Eiras Pérez, J; Estévez Antla, J; 
Fonseca Moretón, T; Izquierdo Fernández, R; Lora Sánchez, A; Martínez Portela, JM; Mena Cao, JI; 
Nogueiras Santas, C; Oujo Pujales, J; Pache Muíños, C; Ríos Rey, T; Sánchez Ventin, V; Sanisidro 
Vilaso, FJ; Torre Díez, JL; Ucha Fernández, J; Vázquez Troitiño, F; Vergara Ruiz, M; G.A.P. Ourense: 
Alberte Castiñeiras, ML; Antolín Novoa; MD; Avila Alonso, AH; Balado Carballido, A;del Alamo 
Alonso, AJ; Eirís Cambre, MA; Fernández Silva, MJ;Ferreira González, MI; González Afonso, E; 
González Reza, E; Lamelas García, JA; Madroño Freire, MJ; Merino Beiro, MO; Outeiriño López, ME; 
Portuburu Izaguirre, MM; Quintela Fernández, A; Rodríguez Domínguez, G; Rodríguez Ferreiros, AM; 
Rojo Fernández, JC; Salgado Gómez, MC; Salgado Novoa, MM; Valencia Veloso, M; Veiga Vázquez, A; 
Vilariño Méndez, CR; G.A.P. Santiago: Bugarín González, R; Caneda Villar, MC; Celemín Colomina, 
I;Cerqueiras Alcalde, MC; Concheiro Coello, G; Estévez Vila, JA; Fernández González, ME; Juiz 
Crespo, MA; Lorenzo Tomé, JJ; Pazo Paniagua, MC; Rojo Grandío, Y; Seco Otero, M; Vázquez 
Cacheiro, J; Ventosa Rial, JJ; Verdes Castro, MC. 
Nursing group: Rodríguez González, A; Losada Mateo, A; González Castroagudín, S; Prado Nistal, A; 
Moreira Iglesias, D; Rojo González, S; Alvarez Sequeiro, J; Rodríguez Rey, L. 
